Justin Fulcher had returned to Charleston, South Carolina in early 2020 after spending roughly a year overseeing RingMD‘s transition from Singapore to Boston. The company had relaunched in the United States in 2019 with a focus on government clients and compliance-grade infrastructure. Then COVID-19 arrived, and the healthcare system’s reluctance to treat telehealth as a frontline tool collapsed almost overnight.
Making the Platform Free During the Pandemic
Fulcher’s response to the pandemic was to offer a white-labelled version of the RingMD platform free of charge to hospitals, clinics, doctors, and healthcare organizations worldwide. The decision reflected the same logic that had shaped every stage of the company’s development: remove the cost barrier, and access follows. “COVID has taken telemedicine and digital healthcare from a nice-to-have to a must-have,” he said at the time.
The offer was well-timed in part because the platform was already built for the kind of conditions the pandemic created. RingMD had been engineered for rural connectivity and low-bandwidth environments, a technical specification that became relevant when healthcare organizations across the country scrambled to move patient interactions online. The platform’s FedRAMP Moderate, FISMA, and HIPAA compliance gave institutional clients the regulatory assurance they needed to move quickly.
That preparation was not accidental. Justin Fulcher had spent years building in markets where infrastructure was absent and institutional trust had to be earned through compliance, not assumed. Southeast Asia had produced a platform designed to function where the healthcare system had not yet arrived. The US government client base had demanded compliance certifications that no consumer-facing product would have required.
By the time the immediate crisis passed, RingMD had demonstrated in practice what Fulcher had been arguing in theory: that telehealth at scale required both the access architecture and the regulatory foundation. The platform he had built from a prototype in Singapore to a compliant government-grade product in the United States had exactly both. See related link for more information.
Find more information about Judd Zebersky on https://x.com/JustinFulcher